Dr. Jordi Monés, the director

Dr. Jordi Monés is an ophthalmologist specialised in diseases of macula, retina and vitreous humour. Graduated in Medicine and Surgery by University of Barcelona, he subsequently specialized in Ophthalmology via MIR at Centro de Oftalmología...
The IMIR
The Institut de la Macula i de la Retina (IMIR) is a center devoted solely to the treatment and research of the macular, retinal and vitreous medical and surgical conditions. Special dedication to clinical research with Clinical Trials in Phase I,II,...
 14.32.33.png)
 14.01.16.png)
 08.18.16.png)

Publications
Intravitreal bevacizumab (Avastin) for choroidal neovascularization secondary to pathological myopia: 6-month results L....
Delay in treating age-related macular degeneration in Spain is associated with progressive vision lossConclussions Delayed...
Management of diabetic macular edema with antiangiogenic therapyEvaluation of: Chun DW. Heier JS. Topping TM, Duker JS, Bankert...
Conferences
02. Symposium “A NEW VISION OF AMD” Dr. Jordi Monés: Efficacy 83rd Congress of the Spanish Society of...
03. Clinical-update in AMD Directors: Jordi Monés i Carilla, Francisco Gómez-Ulla de Irazazábal Level:...
04. Mystery Case. Fluorescein cases in 2007. The Macula Society. June 2007, London
Ensayos Clínicos
Multicenter study OPH 1001 - Research Coordinator

Phase 1 Study of ARC 1905 -Principal investigator and protocol...

Video
Research & Innovation, key factors in combating degenerative diseases of the eye
Summary of presentation "R & I, a key factor in combating degenerative diseases of the eye" by Dr. Jordi Monés. The founder of the Barcelona Macula Foundation has participated as invited to breakfast at La Salle on 17 January...
Institut Macula Retina
To prevent macular degeneration, early detection is important, consistency in treatment and research.
The Pathophysiology of Wet AMD - by Genentech
Ranibizumab: the approved Anti-VEGF therapy for wet AMD, diabetic macular edema and retinal vein oclusion




